# Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds

> **NCT04438174** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Utah** · enrollment: 1 (actual)

## Conditions studied

- Wounds and Injuries

## Interventions

- **DRUG:** Processed Amniotic Fluid
- **OTHER:** Standard of Care Wound Treatment Regimen

## Key facts

- **NCT ID:** NCT04438174
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08
- **Primary completion:** 2023-03
- **Final completion:** 2023-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Enrollment was halted prematurely after enrolling one participant due to difficulty finding eligible participants.
- **Last updated:** 2024-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04438174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04438174, "Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04438174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*